John B. Henneman, III

2015 - NewLink Genetics

In 2015, John B. Henneman, III earned a total compensation of $818.4K as Chief Financial Officer & Secretary at NewLink Genetics, a 80% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$167,992
Option Awards$173,896
Salary$365,200
Stock Awards$87,300
Other$23,994
Total$818,382

Henneman received $365.2K in salary, accounting for 45% of the total pay in 2015.

Henneman also received $168K in non-equity incentive plan, $173.9K in option awards, $87.3K in stock awards and $24K in other compensation.

Rankings

In 2015, John B. Henneman, III's compensation ranked 8,873rd out of 13,638 executives tracked by ExecPay. In other words, Henneman earned more than 34.9% of executives.

ClassificationRankingPercentile
All
8,873
out of 13,638
35th
Division
Manufacturing
3,386
out of 5,190
35th
Major group
Chemicals And Allied Products
1,234
out of 1,854
33rd
Industry group
Drugs
1,006
out of 1,528
34th
Industry
Pharmaceutical Preparations
783
out of 1,182
34th
Source: SEC filing on March 31, 2017.

Henneman's colleagues

We found five more compensation records of executives who worked with John B. Henneman, III at NewLink Genetics in 2015.

2015

Charles Link

NewLink Genetics

Chief Executive & Scientific Officer

2015

Nicholas Vahanian

NewLink Genetics

Chief Medical Officer

2015

Brian Wiley

NewLink Genetics

Chief Commercial Officer

2015

Eugene Kennedy

NewLink Genetics

Chief Medical Officer

2015

Carl Langren

NewLink Genetics

Vice President of Finance

You may also like